EXELIXIS INC (EXEL)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About EXELIXIS INC
Exelixis, Inc. is a NASDAQ-listed biotechnology company that develops and commercializes cancer medicines and other therapies, generating $2.3 billion in FY2025 revenue. Its marketed portfolio centers on CABOMETYX tablets, COMETRIQ capsules, and COTELLIC for oncology, alongside MINNEBRO for hypertension, with commercial activity in the United States and Japan.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
EXELIXIS INC's Technical Indicators Summary
EXEL shows a tilt toward selling pressure with bearish momentum—CCI is deeply negative and MACD is slightly below zero—while the market trades under short and medium moving averages even as it remains above longer 100/200‑day averages. ADX is modest, implying no strong directional conviction, ATR reflects subdued volatility, and OBV is positive, suggesting some accumulation despite the near‑term weakness. The classic pivot is slightly above the current price, indicating nearby resistance. Technical takeaway: Sell.
| Indicator | Value |
|---|---|
RSI (14) | 44.53 |
Stochastic %K (14, 3, 3) | 25.37 |
CCI (20) | -169.12 |
WPR (14) | -76.88 |
Momentum (10) | -2.85 |
MFI | 52.89 |
MACD Level (12, 26) | -0.09 |
Bollinger Bands | $52.78 - $57.64 |
ATR (14) | $1.91 (3.60%) |
ADX (14) | 22.06 |
OBV | 4,733,645 |
Classic Pivot Point | $53.46 |
Fibonacci Pivot Point | $53.46 |
Simple Moving Averages | $46.28 - $55.21(5 indicators) |
Exponential Moving Averages | $47.11 - $54.79(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The tone was slightly negative in the previous session for EXEL, which closed -2.05% below 54.07. EXEL faces a pending investigation per Levi & Korsinsky.
Trading Volume
Below 10d avg (3.3M)
2.6M
vs S&P 500 Today
Underperforming Market
-1.99%
52-Week Position
Upper range
80.6%
Updated: August 11, 2026 at 12:45 UTC